本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Gyre Therapeutics

8.28
-0.1400-1.66%
盤後8.280.00000.00%16:10 EST
成交量:7.56萬
成交額:63.55萬
市值:7.98億
市盈率:211.54
高:8.62
開:8.39
低:8.20
收:8.42
52周最高:13.75
52周最低:6.11
股本:9,633.32萬
流通股本:2,594.58萬
量比:1.24
換手率:0.29%
股息:- -
股息率:- -
每股收益(TTM):0.0391
每股收益(LYR):0.0481
淨資產收益率:10.02%
總資產收益率:5.29%
市淨率:7.83
市盈率(LYR):172.22

資料載入中...

公司資料

公司名字:
Gyre Therapeutics
交易所:
NASDAQ
成立時間:
2002
員工人數:
579
公司地址:
12770 High Bluff Drive,Suite 150,San Diego,California,United States
郵編:
92130
電話:
傳真:
- -
簡介:
Gyre Therapeutics, Inc.在特拉華州註冊成立。該公司及其子公司是一家生物製藥公司,該公司是一家生物製藥公司,致力於研究、開發、製造和商業化治療器官纖維化的創新藥物。

董事

名稱
職位
Ping Zhang
Executive Chair, Interim Chief Executive Officer
David M. Epstein
Independent Director
Gordon G. Carmichael
Independent Director
Renate Parry
Independent Director
Rodney L. Nussbaum
Independent Director
Songjiang Ma
President and Director
Dan Weng
Director
Thomas Eastling
Director

股東

名稱
職位
Ping Zhang
Executive Chair, Interim Chief Executive Officer
Weiguo Ye
Chief Operating Officer
Han Ying
Senior Vice President, Science
Ruoyu Chen
Chief Financial Officer and Principal Accounting Officer
Songjiang Ma
President and Director